ยินดีต้อนรับกลับมา
เข้าร่วม CoinTime
เข้าสู่ระบบ email
สร้างบัญชี email
ตรวจสอบกล่องจดหมายของคุณ
BioMedomics
About
BioMedomics develops advanced quantitative point-of-care (POC) diagnostic platforms and disease-specific diagnostic tests.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $222.95K
- Industries
- Biotechnology,Health Care,Health Diagnostics
- Founded date
- Jan 1, 2006
- Number Of Employee
- 1 - 10
- Operating Status
- Active
BioMedomics, Inc. manufactures and markets bioscience products and medical devices. The company’s products includes deoxyribonucleic acid research reagents; human, mouse, and rat genepool products; tissue array products; and antibodies. It designs and develops real-time cell electronic sensing technology for analyzing cell-based assay procedures. The company offers contract assay services such as cell proliferation, cytotoxicity, adhesion, viability, and invasion. Additionally, it provides drug discovery, research, and development services. BioMedomics is based in Research Triangle Park, North Carolina.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 16, 2015 | Grant | $222.95K | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
